Search Results 1391-1400 of 17812 for Substance+dependence
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization ...
A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...
Drug addiction, Alcohol use disorder. Pagination Doctor search. PrevPrevious Page · Go to page 99 · Go to page 1010 · Go to page 1111 · Go to page 1212 · Go to ...
Drug addiction, Alcohol use disorder. Sondra Schultz, M.D.. Phoenix, AZ. Matt E. Schumann, Ph.D., L.P. ...
... drug-resistant. Featured News. New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison ...
Deep brain stimulation in drug addiction treatment: Research progress and perspective. Frontiers in Psychiatry. 2022; doi:10.3389/fpsyt.2022.858638. Medical ...
Latest stories. Researchers discover new molecular drug targets for progressive neurological disorder featured image. Discovery Science. Researchers discover ...
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines European Journal of Human Genetics. 2025 ...
New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant · Hidden mutation leads to groundbreaking genetic ...
Belantamab mafodotin (GSK2857916) is an antibody-drug ... dependency, during the intervention period and ... Prior treatment with a monoclonal antibody within 30 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.